Professor Hagan Bayley – Founder and Director
Professor Bayley founded OxSyBio in 2014 and leads the ongoing development of the technology.
Educated at the University of Oxford, Professor Bayley spent most of his academic career at leading US academic institutions, including Harvard, MIT, the University of Massachusetts and Texas A&M University. He returned to the UK in 2003 as the Professor of Chemical Biology in the Department of Chemistry at the University of Oxford. Oxford’s Chemistry department is now the largest in the western world, and it has recently completed the construction of state-of-the-art facilities for multidisciplinary chemistry research. The academic standards of the department are regarded as second to none, and the teaching course was recently given the highest possible rankings by two educational authorities.
Professor Bayley’s research interests lie in the exploration of membrane protein structure and function, and the use of molecular engineering techniques that transform these proteins into unique measurement systems for exploring the chemistry of individual molecules. Professor Bayley founded Oxford NanoLabs (now Oxford Nanopore Technologies) in 2005, which is developing a new generation of nanopore-based electronic systems for the analysis of single molecules. Oxford Nanopore has raised in excess of £180m of funding, and in 2014 launched the MinION, a hand-held DNA sequencing device.
Dr. Hadrian Green – Chief Executive Officer
Dr. Green joined OxSyBio with more than a decade of experience working with global pharmaceutical and diagnostics companies as well as biotech companies and governments to drive the translation of science into next generation life-science businesses. This experience with Marakon Associates, Merck, GSK and Ernst & Young spans corporate and business unit strategy & transactions with a particular focus on personalised healthcare, clinical diagnostics, and small molecule and biological drug development. Hadrian graduated in Medicine and practiced across Australasia, the UK and several developing countries before earning a PhD in Molecular Imaging at the University of Cambridge. Hadrian has 12 published papers, is a Fellow of the Cambridge Commonwealth Trust and was previously a bye-fellow of Queens’ College Cambridge.
Dr. Sam Olof – Technical Director
Dr. Olof is currently Technical Director at OxSyBio and a Visiting Scientist in Chemical Biology at the University of Oxford. He received a Masters Degree in Chemistry from Bristol University in 2009, and in 2013 a Ph.D, in Functional Nanomaterials, also at Bristol. His Ph.D work was supervised by Professor Stephen Mann FRS (Chemistry) and Professor Mervyn Miles FRS (Physics), and explored self-assembled artificial cells with advanced microscopy techniques. In 2013 he joined the Bayley Group to investigate the 3D printing of artificial tissues. This work has informed OxSyBio’s efforts in printed cell networks and has led to the submission of 2 patent applications and the raising of £1 m seed funding.